Clinic diagnostic value of MSCT imaging features in nodular lung adenocarcinoma subtype
Wang Jun1(), Zhao Xia2, Li Haifei3, Zhang Cheng1
1Department of Thoracic Surgery, Yantai Affiliated Hospital of Binzhou Medical University, Yantai 264100, China 2Department of Medical Insurance Division, Yantai Affiliated Hospital of Binzhou Medical University, Yantai 264100, China 3Department of Medical Imaging, Yantai Affiliated Hospital of Binzhou Medical University, Yantai 264100, China
Wang Jun, Zhao Xia, Li Haifei, Zhang Cheng. Clinic diagnostic value of MSCT imaging features in nodular lung adenocarcinoma subtype[J]. Journal of International Oncology, 2021, 48(9): 537-543.
National Lung Screening Trial Research Team; Aberle DR, Adams AM, et al. Reduced lung-cancer mortality with low- dose computed tomographic screening[J]. N Engl J Med, 2011, 365(5):395-409. DOI: 10.1056/NEJMoa1102873.
doi: 10.1056/NEJMoa1102873
[2]
Inertnational Early Lung Cancer Action Program Investigators; Henschke CI, Yankelevitz DF, et al. Survival of patients with stage Ⅰ lung cancer detected on CT screening[J]. N Engl J Med, 2006, 355(17):1763-1671. DOI: 10.1056/NEJMoa060476.
doi: 10.1056/NEJMoa060476
[3]
Travis WD, Brambilla E, Noguchi M, et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma[J]. J Thorac Oncol, 2011, 6(2):244-285. DOI: 10.1097/JTO.0b03e318206a221.
doi: 10.1097/JTO.0b03e318206a221
Bahleda R, Hollebecque A, Varga A, et al. PhaseⅠstudy of afatinib combined with nintedanib in patients with advanced solid tumours[J]. Br J Cancer, 2015, 113(10):1413-1420. DOI: 10.1038/bjc.2015.374.
doi: 10.1038/bjc.2015.374
[7]
Wu W, Parmar C, Grossmann P, et al. Exploratory study to identify radiomics classifiers for lung cancer histology[J]. Front Oncol, 2016, 6:71. DOI: 10.3389/fonc.2016.00071.
doi: 10.3389/fonc.2016.00071
[8]
Lee HY, Choi YL, Lee KS, et al. Pure ground-glass opacity neoplastic lung nodules: histopathology, imaging, and management[J]. AJR Am J Roentgenol, 2014, 202(3):W224-W233. DOI: 10.2214/AJR.13.11819.
doi: 10.2214/AJR.13.11819
[9]
Li Q, Fan L, Cao ET, et al. Qantitative CT analysis of pulmonary pure ground-glass nodule predicts histological invasiveness[J]. Eur J Radiol, 2017, 89:67-71. DOI: 10.1016/j.ejrad.2017.01.024.
doi: 10.1016/j.ejrad.2017.01.024
[10]
Fan L, Liu SY, Li QC, et al. Multidetector CT features of pulmonary focal ground-glass opacity: differences between benign and maligant[J]. Br J Radiol, 2012, 85(1015):897-904. DOI: 10.1259/bjr/33150223.
doi: 10.1259/bjr/33150223
pmid: 22128130
[11]
Lee SM, Park CM, Goo JM, et al. Invasive pulmonary adenocarcinomas versus preinvasive lesions appearing as ground-glass nodules: differentiation by using CT features[J]. Radiology, 2013, 268(1):265-273. DOI: 10.101148/radiol.13120949.
doi: 10.101148/radiol.13120949
Si MJ, Tao XF, Du GY, et al. Thin-section computed tomography-histopathologic comparisons of pulmonary focal interstitial fibrosis, atypical adenomatous hyperplasia, adenocarcinoma in situ, and minimally invasive adenocarcinoma with pure ground-glass opacity[J]. Eur J Radiol, 2016, 85(10):1708-1715. DOI: 10.1016/j.ejrad.2016.07.012.
doi: 10.1016/j.ejrad.2016.07.012